Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akhil Rajendra

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Clinical Lymphoma, Myeloma & Leukemia|November 14, 2025
What is the Prognostic Relevance of Responses Less Than a CR to Initial AML Treatment?Akhil Rajendra, Elliot Smith, Eshetu G Atenafu, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 1, 2021
Clinical course of severe COVID19 treated with tocilizumab and antivirals post-allogeneic stem cell transplant with extensive chronic GVHDSumeet Mirgh, Anant Gokarn, Sachin Punatar, et al.
Blood Advances|February 26, 2021
Outcomes and prognostic factors in adolescents and young adults with ALL treated with a modified BFM-90 protocolAkhil Rajendra, Hasmukh Jain, V N Avinash Bonda, et al.
South Asian Journal of Cancer|March 24, 2025
Efficacy and Safety of Low-Dose Nivolumab in Treatment of Advanced Solid Tumors: A Retrospective Audit from Resource-Constrained SettingsAmit Kumar, Akhil Kapoor, Vanita Noronha, et al.
JCO Global Oncology|April 23, 2026
Low-Dose Versus Standard-Dose Abiraterone in Patients With Metastatic Castration-Resistant Prostate Cancer: A Multicenter Randomized Phase III TrialVanita Noronha, Minit Shah, Akhil Kapoor, et al.
Blood Cancer Journal|March 15, 2025
Outcomes and prognostic factors in patients with Burkitt lymphoma/leukemia in adolescents and adults: an experience from hematology cancer consortiumAkhil Rajendra, Manju Sengar, Anu Korula, et al.
Immunology and Cell Biology|September 28, 2021
Comprehensive immune cell profiling depicts an early immune response associated with severe coronavirus disease 2019 in cancer patientsPrashant R Tembhare, Harshini Sriram, Gaurav Chatterjee, et al.
British Journal of Haematology|September 16, 2024
Impact of the COVID-19 pandemic on treatment of patients with acute myeloid leukaemia in IndiaChepsy Philip, Sushil Selvarajan, Lingaraj Nayak, et al.
Cancer Medicine|November 17, 2021
Clinical characteristics, laboratory parameters and outcomes of COVID-19 in cancer and non-cancer patients from a tertiary Cancer Centre in IndiaSumeet P Mirgh, Anant Gokarn, Akhil Rajendra, et al.
Annals of Hematology|July 8, 2024
Treatment challenges and outcomes of older patients with acute myeloid leukemia from IndiaSuvir Singh, Sharon Lionel, Hasmukh Jain, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Clinical Lymphoma, Myeloma & Leukemia|November 14, 2025
What is the Prognostic Relevance of Responses Less Than a CR to Initial AML Treatment?Akhil Rajendra, Elliot Smith, Eshetu G Atenafu, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 1, 2021
Clinical course of severe COVID19 treated with tocilizumab and antivirals post-allogeneic stem cell transplant with extensive chronic GVHDSumeet Mirgh, Anant Gokarn, Sachin Punatar, et al.
Blood Advances|February 26, 2021
Outcomes and prognostic factors in adolescents and young adults with ALL treated with a modified BFM-90 protocolAkhil Rajendra, Hasmukh Jain, V N Avinash Bonda, et al.
South Asian Journal of Cancer|March 24, 2025
Efficacy and Safety of Low-Dose Nivolumab in Treatment of Advanced Solid Tumors: A Retrospective Audit from Resource-Constrained SettingsAmit Kumar, Akhil Kapoor, Vanita Noronha, et al.
JCO Global Oncology|April 23, 2026
Low-Dose Versus Standard-Dose Abiraterone in Patients With Metastatic Castration-Resistant Prostate Cancer: A Multicenter Randomized Phase III TrialVanita Noronha, Minit Shah, Akhil Kapoor, et al.
Blood Cancer Journal|March 15, 2025
Outcomes and prognostic factors in patients with Burkitt lymphoma/leukemia in adolescents and adults: an experience from hematology cancer consortiumAkhil Rajendra, Manju Sengar, Anu Korula, et al.
Immunology and Cell Biology|September 28, 2021
Comprehensive immune cell profiling depicts an early immune response associated with severe coronavirus disease 2019 in cancer patientsPrashant R Tembhare, Harshini Sriram, Gaurav Chatterjee, et al.
British Journal of Haematology|September 16, 2024
Impact of the COVID-19 pandemic on treatment of patients with acute myeloid leukaemia in IndiaChepsy Philip, Sushil Selvarajan, Lingaraj Nayak, et al.
Cancer Medicine|November 17, 2021
Clinical characteristics, laboratory parameters and outcomes of COVID-19 in cancer and non-cancer patients from a tertiary Cancer Centre in IndiaSumeet P Mirgh, Anant Gokarn, Akhil Rajendra, et al.
Annals of Hematology|July 8, 2024
Treatment challenges and outcomes of older patients with acute myeloid leukemia from IndiaSuvir Singh, Sharon Lionel, Hasmukh Jain, et al.
Pageof 2